QSS
PTCT icon

Quantitative Systematic Strategies’s PTC Therapeutics PTCT Stock Holding History

Quantitative Systematic Strategies’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-7,547
Closed -$319K – 283
2021
Q2 		$319K Sell
7,547
-4,920
-39% -$211K 0.11% 321
2021
Q1 		$590K Buy
+12,467
New +$740K 0.09% 337
2020
Q3 		– Sell
-4,147
Closed -$210K – 692
2020
Q2 		$210K Buy
+4,147
New +$204K 0.04% 505
2020
Q1 		– Sell
-6,237
Closed -$300K – 467
2019
Q4 		$300K Sell
6,237
-3,093
-33% -$131K 0.04% 445
2019
Q3 		$316K Sell
9,330
-1,423
-13% -$61.9K 0.07% 326
2019
Q2 		$484K Buy
+10,753
New +$425K 0.09% 254
2018
Q4 		– Sell
-8,914
Closed -$419K – 829
2018
Q3 		$419K Buy
8,914
+2,464
+38% +$102K 0.08% 346
2018
Q2 		$218K Buy
+6,450
New +$201K 0.04% 540
2015
Q1 		– Sell
-5,212
Closed -$274K – 479
2014
Q4 		$274K Buy
+5,212
New +$229K 0.11% 240

Other funds holding PTCT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Quantitative Systematic Strategies's PTCT Position: Q3 2021 in Review

Quantitative Systematic Strategies sold out of PTC Therapeutics (PTCT) in Q3 2021, closing a stake of 7,547 shares — an estimated $319K sold.

Quantitative Systematic Strategies first reported a position in PTCT in Q4 2014 and held it in 9 quarters. The position peaked at $590K in Q1 2021. 182 funds tracked by Wall St. Rank hold PTCT as of Q3 2021.

  • Quantitative Systematic Strategies reported no remaining PTC Therapeutics position as of Q3 2021 after selling out during the quarter.
  • Quantitative Systematic Strategies sold 7,547 PTC Therapeutics shares in Q3 2021, an estimated $319K.
  • Quantitative Systematic Strategies first reported a position in PTC Therapeutics in Q4 2014 and held it in 9 quarters.
  • Quantitative Systematic Strategies's PTC Therapeutics position peaked at $590K in Q1 2021.
  • 182 funds tracked by Wall St. Rank held PTC Therapeutics as of Q3 2021.

Based on Quantitative Systematic Strategies's 13F filing for Q3 2021, filed 16 Nov 2021.